RaySearch Laboratories ABRSLBF +0.81%90 Days Inventory is 137.96 as of Mar. 2026, which is 244% above its 10-year median of 40.09. GuruFocus rates RSLBF with a GF Score™ of 90/100 and a GF Value™ of $17.41 (Fairly Valued). The stock has 2 warning signs investors should review. Among 493 Healthcare Providers & Services companies, RaySearch Laboratories AB ranks worse than 84.58% on this metric.
The historical rank and industry rank for RaySearch Laboratories AB's Days Inventory or its related term are showing as below:
RSLBF'
s Days Inventory Range Over the Past 10 Years
Min: 0.33 Med: 40.09 Max: 141.59
Current: 105.19
During the past 13 years, RaySearch Laboratories AB's highest Days Inventory was 141.59. The lowest was 0.33. And the median was 40.09.
RSLBF's Days Inventory is ranked worse than 84.58% of 493
companies
in the Healthcare Providers & Services industry
Industry Median: 30.04
vs RSLBF: 105.19
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
RaySearch Laboratories AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.66.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RaySearch Laboratories AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.12.
RaySearch Laboratories AB (OTCPK:RSLBF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
RaySearch Laboratories AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RaySearch Laboratories AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
RaySearch Laboratories AB Days Inventory Related Terms
RaySearch Laboratories AB Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RSLBF vs VEEV, BTSG, TEM: Days Inventory Comparison
For the Health Information Services subindustry, RaySearch Laboratories AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RaySearch Laboratories AB Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where RaySearch Laboratories AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RaySearch Laboratories AB (RSLBF) has a Days Inventory of 137.96 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on RaySearch Laboratories AB and its competitors. This is 244% above median its historical median of 40.09. Over the past decade, RaySearch Laboratories AB's Days Inventory has ranged from 0.33 to 141.59. According to the industry distribution chart, RaySearch Laboratories AB ranks #417 out of 493 companies in the Healthcare Providers & Services industry, placing it in the top 84.6%.
Is RaySearch Laboratories AB's Days Inventory too high?
RaySearch Laboratories AB's current Days Inventory of 137.96 is 244% above median its 10-year median of 40.09. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 141.59. The Healthcare Providers & Services industry median Days Inventory is 30.04. RaySearch Laboratories AB's value of 137.96 is 359.3% above this industry median. Based on the distribution chart, RaySearch Laboratories AB ranks #417 out of 493 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, RaySearch Laboratories AB has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Days Inventory compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, RaySearch Laboratories AB ranks #417 out of 493 companies for Days Inventory. This places RaySearch Laboratories AB in the lower half of its industry. The industry median Days Inventory is 30.04. RaySearch Laboratories AB's value of 137.96 is 359.3% above this benchmark. Historically, RaySearch Laboratories AB's own Days Inventory has ranged from 0.33 to 141.59 over the past decade. While the company's 10-year median is 40.09 vs. the industry median of 30.04, RaySearch Laboratories AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 30.04, based on 493 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RaySearch Laboratories AB's current Days Inventory of 137.96 is 359.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on RaySearch Laboratories AB and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 30.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RaySearch Laboratories AB's current Days Inventory is 137.96, which is 244% above median its own 10-year median of 40.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (RSLBF) is currently considered Fairly Valued. The stock's GF Value™ is $17.41, compared to a current price of $21.17 — trading 21.6% above its estimated fair value. The current Days Inventory is 137.96, which is 244% above median its 10-year median of 40.09 and 359.3% above the Healthcare Providers & Services industry median of 30.04. RaySearch Laboratories AB's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For RaySearch Laboratories AB (RSLBF), the current Days Inventory is 137.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RaySearch Laboratories AB (RSLBF) Overvalued in 2026?
Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued.
The current stock price of $21.17 is trading 21.6% above its estimated GF Value™ of $17.41.
GuruFocus considers RaySearch Laboratories AB to be Fairly Valued.
Key valuation signals for RSLBF:
Days Inventory: 137.96 (244% above median its 10-year median of 40.09)
GF Value™: $17.41 vs. price of $21.17 (21.6% above fair value)
Industry Position: 359.3% above the Healthcare Providers & Services median (#417 of 493)
No single metric tells the full story. See the RSLBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
90GF Score
Get the complete analysis for RSLBF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSLBF has been successfully added to your 
